Example: Heart Attack

Clinical Trials on Tick-borne Encephalitis

Total 43 results

NCT03956446

Recruiting

Tick-borne Encephalitis and Borrelial Antibodies in Serum

Conditions: Tick Borne Encephalitis
NCT04648241

Not yet recruiting

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Conditions: Tick-Borne Encephalitis
NCT02463942

Unknown status

Tick-borne Encephalitis and Positive Borrelial Antibodies

Conditions: Tick-borne Encephalitis
NCT01106482

Completed

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Conditions: Tick Borne Encephalitis (TBE)
NCT01562444

Completed

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Conditions: Tick Borne Encephalitis
NCT00118924

Completed

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Conditions: Tick-Borne Encephalitis
NCT03958058

Completed

Tick-borne Encephalitis and Possible Borrelial Serology

Conditions: Tick Borne Encephalitis; Lyme Disease
NCT01710189

Completed

Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac

Conditions: Tick-Borne Encephalitis
NCT02318069

Unknown status

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Conditions: Tick-borne Encephalitis
NCT01361776

Completed

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Conditions: Tick-borne Encephalitis
NCT00804219

Completed

Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination

Conditions: Tick-borne Encephalitis
NCT00890422

Unknown status

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine

Conditions: Tick Borne Encephalitis
NCT01991067

Completed

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Conditions: Tick Borne Encephalitis
NCT01582698

Completed

TBE Seropersistence up to 10 Years After First Booster in Adults

Conditions: Tick-borne Encephalitis (TBE)
NCT04017052

Active, not recruiting

Application of a TBE-Vaccine in Obese Persons

Conditions: Tick Borne Encephalitis
NCT01031537

Terminated

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)

Conditions: Tick-Borne Encephalitis; Encephalitis, Tick-Borne; Tick-Borne Disease; Glycoprotein E, Flavivirus; NSI Protein, Flavivirus
NCT00941590

Unknown status

Postencephalitic Symptoms After Tick Borne Encephalitis

Conditions: Central European Encephalitis
NCT00161863

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Conditions: Tick-borne Encephalitis
NCT00161798

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Conditions: Tick-borne Encephalitis
NCT00161785

Completed

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Conditions: Tick-borne Encephalitis
NCT00161772

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Conditions: Tick-borne Encephalitis
NCT04573205

Not yet recruiting

Primary TBE Vaccination for the Elderly

Conditions: Tick-borne Encephalitis; Vaccine
NCT02511535

Completed

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Conditions: Vaccine Responsiveness in Allergy; Vaccine Responsiveness During Allergy De-sensitization Treatment
NCT00894686

Completed

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Conditions: Encephalitis, Tick-Borne
NCT00161967

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Conditions: Encephalitis, Tick-Borne